Skip to search.
 FTSE 100 Down 1.21%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
4.71 Down 0.05(1.05%) 23 Sep 21:00
Prev Close:4.76
Open:4.78
Bid:2.59 x 100
Ask:N/A
1y Target Est:6.33
Beta:1.95839
Next Earnings Date: 7-Nov-16BCRX Earnings announcement
Day's Range:4.60 - 4.84
52wk Range:1.63 - 12.88
Volume:914,893
Avg Vol (3m):961,356
Market Cap:347.13m
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BCRX at this time.

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.05%347.13m
GSKDown 0.37%105.53b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.03
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):-0.23

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback